Compare Erasca Inc. Common Stock (ERAS) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Erasca Inc. Common Stock vs Roivant Sciences Ltd. Common Shares — how do they compare? Erasca Inc. Common Stock trades at $16.03 (market cap $5.40B), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 4.6× Erasca Inc. Common Stock's market cap, and Erasca Inc. Common Stock is more actively traded (9,533,185 versus 6,279,442). Which is the better fit depends on your goals — on Pluang, investors hold Erasca Inc. Common Stock for 0 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| ERAS | ROIV | |
|---|---|---|
Market Cap | $5.40B | $24.72B |
Volume | 9,533,185 | 6,279,442 |
Sector | Health | Health |
52-Week High | $22.47 | $41.81 |
52-Week Low | $2.20 | $16.04 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $5.18B | $20.99B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Erasca Inc. Common Stock
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
